Quest Diagnostics IncorporatedDGXNYSE
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank56
5Y CAGR-6.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
-6.3%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.38% |
| Q3 2025 | -13.15% |
| Q2 2025 | 27.41% |
| Q1 2025 | -0.51% |
| Q4 2024 | -1.49% |
| Q3 2024 | -1.95% |
| Q2 2024 | 17.82% |
| Q1 2024 | 1.16% |
| Q4 2023 | -13.57% |
| Q3 2023 | -4.78% |
| Q2 2023 | 16.76% |
| Q1 2023 | 101.12% |
| Q4 2022 | -59.36% |
| Q3 2022 | 10.05% |
| Q2 2022 | -33.00% |
| Q1 2022 | -6.90% |
| Q4 2021 | -22.38% |
| Q3 2021 | -18.61% |
| Q2 2021 | 43.47% |
| Q1 2021 | -17.76% |
| Q4 2020 | 1.90% |
| Q3 2020 | 204.35% |
| Q2 2020 | 86.49% |
| Q1 2020 | -60.64% |
| Q4 2019 | 18.24% |
| Q3 2019 | -4.79% |
| Q2 2019 | 36.89% |
| Q1 2019 | 31.18% |
| Q4 2018 | -40.38% |
| Q3 2018 | -2.50% |
| Q2 2018 | 23.08% |
| Q1 2018 | -30.11% |
| Q4 2017 | 57.63% |
| Q3 2017 | -15.71% |
| Q2 2017 | 17.65% |
| Q1 2017 | 7.21% |
| Q4 2016 | -18.98% |
| Q3 2016 | -0.72% |
| Q2 2016 | 94.37% |
| Q1 2016 | -45.80% |